www.fdanews.com/articles/122061-astellas-to-buy-japanese-other-rights-to-ibs-drug
Astellas to Buy Japanese, Other Rights to IBS Drug
November 10, 2009
Astellas Pharma, Japan’s No. 2 drugmaker, said it will buy the rights to develop and sell U.S. firm Ironwood Pharmaceuticals’ drug
for irritable bowel syndrome in Japan and other parts of Asia.
CNBC
CNBC